(Q39834183)

English

Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphyloc

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphyloc (English)

1 reference

Europe PubMed Central

15 September 2017

Pseudomonas aeruginosa

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Staphylococcus epidermidis

object named as

Staphylococcus epidermidis

1 reference

based on heuristic

inferred from title

Ellie J. C. Goldstein

1

object named as

E J Goldstein

1 reference

Europe PubMed Central

15 September 2017

Diane M. Citron

2

object named as

D M Citron

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

1 July 1985

1 reference

Europe PubMed Central

15 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

15 September 2017

28

1 reference

Europe PubMed Central

15 September 2017

1

1 reference

Europe PubMed Central

15 September 2017

160-162

1 reference

Europe PubMed Central

15 September 2017

In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176333

22 September 2017

In vitro activity of HR 810, a new cephalosporin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176333

22 September 2017

Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176333

22 September 2017

Cefotaxime: A Review of in Vitro Antimicrobial Properties and Spectrum of Activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176333

22 September 2017

Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176333

25 September 2017

The clinical significance of tolerance of Staphylococcus aureus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176333

15 June 2018

Resistance of methicillin-resistant staphylococcus aureus to third-generation cephalosporins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176333

15 June 2018

Enterococcal sensitivity to third generation cephalosporins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176333

15 June 2018

The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=176333

20 August 2018

Treatment of infections due to methicillin-resistant Staphylococcus aureus

1 reference

https://pubmed.ncbi.nlm.nih.gov/3929677

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/3929677

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime: aspects of efficacy and tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/3929677

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals

1 reference

https://pubmed.ncbi.nlm.nih.gov/3929677

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.28.1.160

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39834183&oldid=2091174249"